Quest Diagnostics Reports Q3 Earnings Beat with Revenue Growth of 9.9%
Quest Diagnostics (NYSE: DGX) reported third-quarter financial results that exceeded analyst expectations for both earnings and revenue. The company posted a Non-GAAP earnings per share (EPS) of $3.00, surpassing estimates by $0.13, while total revenue reached $3.1 billion, representing a 9.9% increase year-over-year and beating projections by $50 million. Following these strong results, the company updated its full-year 2026 revenue guidance. Quest Diagnostics now expects annual revenues for 2026 to fall within the range of $12.065 billion to $12.105 billion.
Tickers: $DGX